Scienture Holdings, Inc. announced the entry into a securities purchase agreement with institutional investors.
The agreement involves the purchase of 3,225,000 shares of common stock.
The offering price is $1.20 per share with expected gross proceeds of approximately $3.9 million.
Purchase Agreement Details
3,225,000 shares of common stock to be purchased at $1.20 per share.
Gross Proceeds
Expected gross proceeds of about $3.9 million before deductions.
Maxim Group LLC Involvement
Maxim Group LLC is the sole placement agent for the offering.
Registration Statement
Offering made under the effective Form S-3 (File No. 333-289198) filed with the SEC on August 1, 2025.
Important Note
This press release does not constitute an offer to sell securities.
- Scienture Holdings focuses on providing value through pharmaceutical products.
- The company aims to address unmet market needs with novel specialty products.
The securities purchase agreement represents a significant step for Scienture Holdings in raising funds for its operations and product development. The involvement of institutional investors indicates confidence in the company's future prospects.